Sateesh C. Babu, MDProfessor of Surgery
New York Medical College
Attending Vascular Surgeon
Westchester Medical Center
Valhalla, New York
SATEESH C. BABU, MD - SCHEDULE FOR VEITHsymposium™
Thursday, November 20, 2025
Session ModeratorSESSION 60: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, DCBS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27)
Friday, November 21, 2025
PresenterSESSION 94: NEW DEVELOPMENTS IN TREATING ARTERIAL (INCLUDING AORTIC) GRAFT AND ENDOGRAFT INFECTIONS Infected Axillary Artery Prosthetic Graft Stumps: How Best To Deal With Them Without Total Graft Excision
9:02 AM - 9:07 AM
View Slides in PDF
SATEESH C. BABU, MD - ASSOCIATE FACULTY SCHEDULE FOR VEITHsymposium™
Wednesday, November 19, 2025
ModeratorSESSION 2: Abdominal Aorta – Part II
Martin R. Back, MDProfessor of Surgery
University of Florida
Chief, Division of Vascular Surgery
Gainesville, Florida

Charles J. Bailey, MDAssistant Professor of Surgery
Emory University
Director, Limb Preservation & Peripheral Arterial Disease
Emory University Hospital
Atlanta, Georgia
CHARLES J. BAILEY, MD - SCHEDULE FOR VEITHsymposium™
Thursday, November 20, 2025
PresenterSESSION 60: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, DCBS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27)
Why The Zilver PTX DES (Cook) Is A Durable Effective Treatment For Long Fem-Pop Lesions: Based On Worldwide Trials And Experience: DES Choice (Zilver PTX And Eluvia – Boston Scientific) Can Impact Patient Well Being: 3-Year Results From The REAL-DES Trial
2:30 PM - 2:35 PM
View Slides in PDF
PresenterSESSION 63: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR CLOT REMOVAL OR EMBOLIZATION (SEE ALSO SESSION 30)
Increased Procedural Efficacy And Decreased Cost Are Associated With Use Of Computed-Assisted Vacuum Thrombectomy (Penumbra Indigo And Lightning Flash) To Treat ALI: Is Open Thrombectomy Ever Required
4:55 PM - 5:00 PM
View Slides in PDF
Friday, November 21, 2025
PresenterSESSION 86: NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS: UPDATE ON MESH COVERED STENTS AND TCAR (TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION)
DEBATE: Why We Do NOT Need An RCT Comparing TCAR With Other Treatments: Real-World Data Prove Its Safety, Efficacy, And Superiority As A Treatment For Carotid Stenosis
9:00 AM - 9:05 AM
View Slides in PDF

Amanda Baker, MDAssistant Professor in Radiology and Neurosurgery
Albert Einstein Medical School
Attending
Montefiore Medical Center
Bronx, New York
Jonathan Bath, MDAssociate Professor of Surgery
University of Missouri
Program Director for Vascular Fellowship
University of Missouri
Columbia, Missouri
Iris Baumgartner, MDProfessor of Internal Medicine & Angiology
Vasc Alliance AG, Hirslanden Clinic
Attending Doctor
Attending Doctor & Co-Founder Vasc Alliance
Bern, Switzerland

Hernan A. Bazan, MD, DFSVS, FACSChief
Sutter Health
Department of Vascular/Endovascular Surgery
California Pacific Medical Center - SWBMG
San Francisco, California
HERNAN A. BAZAN, MD, DFSVS, FACS - SCHEDULE FOR VEITHsymposium™
Tuesday, November 18, 2025
Session ModeratorSESSION 11: UPDATES ON TREATMENTS FOR INTRACRANIAL ARTERIAL DISEASE; INVASIVE ENDOVASCULAR TREATMENT FOR ACUTE STROKES; COMBINED CAROTID STENOSIS AND INTRACRANIAL CLOT OR DISEASE; CAROTID DISSECTIONSPresenterSESSION 11: UPDATES ON TREATMENTS FOR INTRACRANIAL ARTERIAL DISEASE; INVASIVE ENDOVASCULAR TREATMENT FOR ACUTE STROKES; COMBINED CAROTID STENOSIS AND INTRACRANIAL CLOT OR DISEASE; CAROTID DISSECTIONSFrailty Scores And Other Variables Impact The Outcomes Of Urgent Carotid Interventions In Acute Stroke Patients: A Comprehensive Analysis Of Risk And Prognosis Shows That Stroke Severity Is The Most Important Determining Factor
9:34 AM - 9:39 AM
View Slides in PDF
Wednesday, November 19, 2025
PresenterSESSION 32: CATHETER-BASED TREATMENTS FOR RESISTANT HYPERTENSION; MANAGEMENT OF CARDIAC PROBLEMS, CORONARY DESS, SMOKING AND TRANSFUSION IN VASCULAR SURGERY PATIENTS; PREVENTING VASCULAR AND CARDIAC COMPLICATIONS
What Are The Molecular Mechanisms Underlying Carotid And Coronary Plaque Rupture: Can They Be Modified By Drugs In The Future
7:54 AM - 7:59 AM
View Slides in PDF
HERNAN A. BAZAN, MD, DFSVS, FACS - ASSOCIATE FACULTY SCHEDULE FOR VEITHsymposium™
Wednesday, November 19, 2025
ModeratorSESSION 2: Abdominal Aorta – Part II

Robert E. Beasley, MD, FSIR, FSCAIMedical Director of Research
Palm Vascular Centers
Vascular Specialist
Palm Vascular Centers
Miami Beach, Florida
ROBERT E. BEASLEY, MD, FSIR, FSCAI - SCHEDULE FOR VEITHsymposium™
Wednesday, November 19, 2025
PresenterSESSION 24: NEW DEVELOPMENTS IN ATHERECTOMY AND STENTS (UNCOATED AND COATED) Update On The BioMimics 3D Spiral Flow Stent (From Veryan Medical): How Does It Work And Is Its Patency Equal To That Of DESs
8:29 AM - 8:34 AM
View Slides in PDF
PresenterSESSION 26: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBS) AND DRUG ELUTING STENTS (DESS): UPDATES ON PACLITAXEL TOXICITY, RANDOMIZED CONTROLLED TRIALS
(RCTS) AND BTK LESION TREATMENTS WITH DCBS AND DESS
Patency And Wound Healing Results Of The 3-French Compatible Microstent (From Micro Medical) Compare Favorably With POBA For BTK Lesions: From The STAND RCT: Antegrade And Retrograde Insertions Are Possible
11:24 AM - 11:29 AM
View Slides in PDF
Thursday, November 20, 2025
PresenterSESSION 60: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, DCBS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27)
Managing Complex Lower Extremity Disease: Experience With The Revolution Atherectomy System (From Rex Medical): Advantages And Experience
2:00 PM - 2:05 PM
View Slides in PDF
PresenterSESSION 61: NEW OR IMPROVED ENDOVASCULAR DEVICE COMBINATIONS FOR LOWER EXTREMITY AND COMPLEX TEVAR TREATMENTS: ANGIOPLASTY BALLOON IMPROVEMENTS
The Ultrascore Scoring Balloons (From BD) For PTA: How Does It Work: Advantages, Clinical Experience And Current Status
3:42 PM - 3:47 PM
View Slides in PDF


Adam Beck, MDDivision Director Vascular Surgery and Endovascular Therapy
University of Alabama at Birmingham
Professor of Surgery
UAB Medicine
Birmingham, Alabama
ADAM BECK, MD - SCHEDULE FOR VEITHsymposium™
Tuesday, November 18, 2025
PresenterSESSION 5: NEW DEVELOPMENTS IN ABDOMINAL AORTIC ANEURYSM (AAA) ETIOLOGY, DETECTION, TREATMENT AND EVAR Computer Analysis Of CT Factors Determining AAA Wall Weakness/Strength Of Areas In AAAs Predicts Rupture Risk Independent Of Size And Post EVAR Neck Behavior: The ViTAA System
1:48 PM - 1:53 PM
View Slides in PDF
Friday, November 21, 2025
Session ModeratorSESSION 85: PROGRESS IN THE PREVENTION AND TREATMENT OF SPINAL CORD ISCHEMIA (SCI) ASSOCIATED WITH THE TREATMENT OF THORACIC, THORACOABDOMINAL AND COMPLEX ABDOMINAL ANEURYSMS PresenterSESSION 85: PROGRESS IN THE PREVENTION AND TREATMENT OF SPINAL CORD ISCHEMIA (SCI) ASSOCIATED WITH THE TREATMENT OF THORACIC, THORACOABDOMINAL AND COMPLEX ABDOMINAL ANEURYSMS What Does The US Aortic Research Consortium (ARC) Tell Us About SCI And CSF Drainage: Decreased Prophylactic Use Of The Latter Seems Beneficial Except For A Few High-Risk Patients: Therapeutic Use Continues To Have Value
7:40 AM - 7:45 AM
View Slides in PDF
MISCELLANEOUS ASSIGNMENTS AT VEITHsymposium
VASCULAR FELLOWS & RESIDENTS CAREER DEVELOPMENT PROGRAM
FRIDAY, NOVEMBER 21, 2025
AMERICAS HALL 1 NORTH, 3RD FLOOR
PRESENTER
8:41 AM – 8:49 AM
Do I Need To Do An Added Fellowship In Advanced Aortic Interventions Before Starting My First Job?

Jean Pierre Becquemin, MD, FRCSProfessor of Vascular Surgery
University of Paris XII
Vascular Surgeon
Saint-Clément-de-Rivière, France
JEAN PIERRE BECQUEMIN, MD, FRCS - SCHEDULE FOR VEITHsymposium™
Tuesday, November 18, 2025
PresenterSESSION 6: MORE ABOUT AAAS AND EVAR, STANDARD AND COMPLEX: UPDATES ON PHYSICIAN MODIFIED ENDOGRAFTS (PMEGS) AND GUIDELINES
Colonic Ischemia Following EVAR Repair: Current Concepts About Etiology, Diagnosis, Prevention, Treatment And Outcomes
2:46 PM - 2:51 PM
Power Point Presentation with Synched Audio
View Slides in PDF
Thursday, November 20, 2025
PresenterSESSION 57: NEW OR IMPROVED DEVICES FOR THORACOABDOMINAL ANEURYSM (TAAA) REPAIRS AND THORACIC AORTIC LESION REPAIRS (TEVAR)
Valiant Captiva (Medtronic) For TEVAR: Advantages, Limitations And 5-Year Results For Various Aortic Lesions
10:38 AM - 10:43 AM
Power Point Presentation with Synched Audio
View Slides in PDF

Christian A. Behrendt, MDAssociate Professor
Asklepios Medical School Hamburg
Chief, Vascular Surgery and Medical Director
Asklepios Clinic Hamburg Wandsbek, Department of Vascular and Endovascular Surgery
Hamburg, Germany

Sarah Bellemare, MDAssociate Professor of Surgery
Albert Einstein College of Medicine
Hepatobiliary and Liver Transplant Surgeon
Montefiore Medical Center
New York, New York
Janna Bentley, MDMedical Director
Lakeshore Vein & Aesthetics Clinic
British Columbia, Canada
Todd Berland, MDProfessor of Surgery
New York University
Vascular Surgeon
New York University
New York, New York

Colin D. Bicknell, MD, FRCSProfessor
Imperial College London
Consultant
Imperial College Healthcare NHS Trust
London, United Kingdom
COLIN D. BICKNELL, MD, FRCS - SCHEDULE FOR VEITHsymposium™
Tuesday, November 18, 2025
PresenterSESSION 7: MORE NEW DEVELOPMENTS IN THE TREATMENT OF THORACIC AORTIC PATHOLOGY INCLUDING CORAL REEF AORTA
Stenting (Open vs. Covered) Of Visceral Branches For TEVAR In Uncomplicated Type B Aortic Dissections (uTBADs): When Is It Necessary And How Does It Improve Results (From The EARNEST Trial)
4:14 PM - 4:19 PM
View Slides in PDF
Wednesday, November 19, 2025
PresenterSESSION 43: NEW DEVELOPMENTS IN AAA BEHAVIOR, TREATMENT AND STANDARD INFRARENAL EVAR: THE INFLUENCE OF DIABETES, BLOOD PRESSURE, AGE, ETC. ON AAA GROWTH; IMPROVED ULTRASOUND SURVEILLANCE, LOCAL ANESTHESIA FOR EVAR, 3D CTA ANALYSIS, CONSEQUENCES OF AAAS LOST TO FOLLOW-UP AND ALL AAAS ARE NOT TIME BOMBS WAITING TO EXPLODE
How Do Arterial Blood Pressure Levels Influence AAA Growth Rates: Does Controlling The Blood Pressure Slow Growth Rates
1:18 PM - 1:23 PM
View Slides in PDF

Jean Bismuth, MDProfessor
University of South Florida
Professor
Tampa General Hospital
Tampa, Florida

James H. Black, III, MDThe David Goldfarb, MD Professor of Surgery
The Johns Hopkins University School of Medicine
Chief and Regional Director of Vascular Surgery and Endovascular Therapy
The Johns Hopkins Hospital and Johns Hopkins Medicine
Baltimore, Maryland
JAMES H. BLACK, III, MD - SCHEDULE FOR VEITHsymposium™
Tuesday, November 18, 2025
Session ModeratorSESSION 16: PROGRESS IN THE TREATMENT OF AORTIC COARCTATIONS AND EXPERT TECHNICAL SKILLS FOR OPEN VASCULAR OPERATIONSWednesday, November 19, 2025
Session ModeratorSESSION 44: MORE NEW DEVELOPMENTS IN AAAS: ENDOVASCULAR TREATMENTS WITH HERITABLE AORTIC DISEASE (CONNECTIVE TISSUE GENETIC DISORDERS - CTDS): HOW DOES INTRASAC THROMBUS LOAD AFFECT AAA BEHAVIOR AND PROGNOSIS AFTER EVARPresenterSESSION 44: MORE NEW DEVELOPMENTS IN AAAS: ENDOVASCULAR TREATMENTS WITH HERITABLE AORTIC DISEASE (CONNECTIVE TISSUE GENETIC DISORDERS - CTDS): HOW DOES INTRASAC THROMBUS LOAD AFFECT AAA BEHAVIOR AND PROGNOSIS AFTER EVAREndovascular (Endograft) Therapy For Marfan And Other CTDs: When Is It Indicated As The Primary Treatment Or After Failed Open Repair And When Is It Not: Is It Time For A Guideline Change
2:36 PM - 2:41 PM
View Slides in PDF
Thursday, November 20, 2025
PresenterSESSION 47: EXCITING NEW OR REDISCOVERED TECHNIQUES, DEVICES, CONCEPTS Current Concepts In The Treatment Of Vascular Ehlers Danlos Syndrome (EDS): How To Make Treatment Outcomes And Operations For Complications Successful: Technical Tips
7:38 AM - 7:43 AM
View Slides in PDF
JAMES H. BLACK, III, MD - ASSOCIATE FACULTY SCHEDULE FOR VEITHsymposium™
Thursday, November 20, 2025
ModeratorSESSION 10: Abdominal Aorta & Thoracoabdominal – Part IV

Jan D. Blankensteijn, MDAssociate Professor of Vascular Surgery
Amsterdam UMC
Amsterdam, The Netherlands
JAN D. BLANKENSTEIJN, MD - SCHEDULE FOR VEITHsymposium™
Tuesday, November 18, 2025
PresenterSESSION 5: NEW DEVELOPMENTS IN ABDOMINAL AORTIC ANEURYSM (AAA) ETIOLOGY, DETECTION, TREATMENT AND EVAR If Type 2 Endoleaks, Which Are Common After EVAR, Are So Dangerous, Where Are All The Post EVAR Ruptures From Them: Maybe They Aren't So Dangerous: When Must They Be Treated
1:30 PM - 1:35 PM
View Slides in PDF
Thursday, November 20, 2025
Session ModeratorSESSION 49: MORE PROGRESS IN F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAS AND TAAAS; AND RELATED TOPICS
John Blebea, MD, MBAClinical Professor of Surgery
Central Michigan University College of Medicine
Clinical Professor of Vascular Surgery
Central Michigan University
Saginaw, Michigan
Erwin Blessing, MDProfessor
University Hospital Hamburg-Eppendorf
Clinical Director
University Heart and Vascular Center
Hamburg, Germany

George Blessios, MD, PhDClinical Assistant Professor
University of Buffalo
Director, Access Surgery of WNY
Access Surgery of WNY
Buffalo, New York

Dittmar Boeckler, Prof. Dr. Professor of Surgery
University of Heidelberg
Prof. Dr. med.
University Hospital of Heidelberg
Heidelberg, Germany
DITTMAR BOECKLER, PROF. DR. - SCHEDULE FOR VEITHsymposium™
Tuesday, November 18, 2025
Session ModeratorSESSION 6: MORE ABOUT AAAS AND EVAR, STANDARD AND COMPLEX: UPDATES ON PHYSICIAN MODIFIED ENDOGRAFTS (PMEGS) AND GUIDELINES
PresenterSESSION 7: MORE NEW DEVELOPMENTS IN THE TREATMENT OF THORACIC AORTIC PATHOLOGY INCLUDING CORAL REEF AORTA
Long-Term Outcomes Of Endovascular Treatment For TBADs: Failure Modes: What Secondary Interventions Are Required: Is Late Graft Migration An Issue
4:08 PM - 4:13 PM
View Slides in PDF
Thursday, November 20, 2025
PresenterSESSION 47: EXCITING NEW OR REDISCOVERED TECHNIQUES, DEVICES, CONCEPTS The Role Of The Vascular Surgeon In Treating Perinatal Hemorrhage: Endovascular Iliac Balloon Occlusion Can Be Life Saving: How And Where Balloons Should Be Placed
7:14 AM - 7:19 AM
View Slides in PDF
Friday, November 21, 2025
PresenterSESSION 100: ADVANCES IN THE ENDO AND OPEN TREATMENT OF VASCULAR TRAUMAVascular Injuries After Blunt Abdominal Trauma: Diagnosis And Management: When Endo, When Open Treatment
4:00 PM - 4:05 PM
View Slides in PDF

Michel J. Bosiers, MDUniversity Hospital Bern
Senior Consultant
University Hospital Bern
Bern, Switzerland
MICHEL J. BOSIERS, MD - SCHEDULE FOR VEITHsymposium™
Tuesday, November 18, 2025
PresenterSESSION 22: MORE HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE, CLTI AND ITS TREATMENTS
3-Year Outcomes Of The MOTIV Drug Eluting Bioresorbable Scaffold (Reva Medical) To Treat BTK Artery Lesions
5:24 PM - 5:29 PM
View Slides in PDF
Thursday, November 20, 2025
PresenterSESSION 57: NEW OR IMPROVED DEVICES FOR THORACOABDOMINAL ANEURYSM (TAAA) REPAIRS AND THORACIC AORTIC LESION REPAIRS (TEVAR)
Comparative Analysis Of The Results Of Various Off-The-Shelf (OTS) Devices For Treating TAAAs
9:20 AM - 9:25 AM
View Slides in PDF
PresenterSESSION 60: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, DCBS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27)
3-Year Results With Another Drug Eluting Bioresorbable Stent (Motiv From REVA) To Treat BTK Lesions: How Is This Device Different, Advantages And Limitations
2:42 PM - 2:47 PM
View Slides in PDF

Oscar H. Bottini, MDProfessor of Surgery
Germany Hospital of Buenos Aires
Clinical Hospital Buenos Aires University
Buenos Aires University
Buenos Aires, Argentina

Lee Bouwman, MD, PhDMaastricht university
Professor
Zuyderland Medical Center
Spaubeek, The Netherlands
LEE BOUWMAN, MD, PHD - SCHEDULE FOR VEITHsymposium™
Tuesday, November 18, 2025
PresenterSESSION 22: MORE HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE, CLTI AND ITS TREATMENTS
Value Of Index Of Microcirculatory Resistance (IMR), Optical Coherence Tomography (OCT), BTK-Flow Reserve And Fractional Flow Reserve (FFR) In BTK Lesions: How To Perform These Measurements
4:30 PM - 4:35 PM
View Slides in PDF
Wednesday, November 19, 2025
PresenterSESSION 42: PROGRESS IN TREATING ILIAC ANEURYSMS; ILIAC BRANCHED DEVICES (IBDS); UPDATE ON FLOW MODULATING AND BARE STENTS FOR TREATING ANEURYSMS AND DISSECTIONS Advantages And Current Status Of The Artivion IBD Device For Treating Common And Internal Iliac Artery Aneurysms: From The PLIANT II Multicenter Study: When Will This Device Be Available In The US
11:04 AM - 11:09 AM
View Slides in PDF
Thursday, November 20, 2025
PresenterSESSION 57: NEW OR IMPROVED DEVICES FOR THORACOABDOMINAL ANEURYSM (TAAA) REPAIRS AND THORACIC AORTIC LESION REPAIRS (TEVAR)
What Are Semi Branches In The Artivion Inner Branched Custom-Made Aortic Endograft (E-xtra Design MultiBranch) For Pararenal Aneurysms And How Do They Reduce Aortic Coverage: Advantages, Limitations And Results
10:08 AM - 10:13 AM
View Slides in PDF

Jonathan R. Boyle, MD, MA (Cantab), FRCSAffiliate Assistant Professor
Department of Surgery
Cambridge University
Consultant Vascular Surgeon & Affiliate Assistant Professor
Cambridge University Hospitals NHS Trust
Cambridge, United Kingdom
JONATHAN R. BOYLE, MD, MA (CANTAB), FRCS - SCHEDULE FOR VEITHsymposium™
Tuesday, November 18, 2025
PresenterSESSION 6: MORE ABOUT AAAS AND EVAR, STANDARD AND COMPLEX: UPDATES ON PHYSICIAN MODIFIED ENDOGRAFTS (PMEGS) AND GUIDELINES
Are Re-Intervention Rates After EVAR Influenced By Device Type And Manufacturer: What Is The Mechanism Responsible For Differences
2:40 PM - 2:45 PM
View Slides in PDF
Wednesday, November 19, 2025
PresenterSESSION 23: GENERALITIES IN THE TREATMENT OF LOWER EXTREMITY OCCLUSIVE DISEASE, CLTI AND THEIR MEDICAL TREATMENT: SOME NEW CONCEPTS
How Does Early Intervention For Critical Limb Threatening Ischemia (CLTI) Save Legs And Lives: The Earlier Ischemia Is Corrected, The Better
6:58 AM - 7:03 AM
View Slides in PDF

Kursat A. Bozkurt, MDProfessor
Istanbul University Cerrahpasa Medical Faculty
Dr
Department of Cardiovascular Surgery
Istanbul, Turkey
Daniela Branzan, MDProfessor of Vascular Surgery
Technical University Munich
Head of the Clinic for Vascular and Endovascular Surgery
University Hospital of TUM
Munich, Germany

Clayton J. Brinster, MDAssociate Professor
Keck School of Medicine of USC
Director, Genetic Aortic and Related Disorders Center
Keck School of Medicine of USC
Los Angeles, California
CLAYTON J. BRINSTER, MD - SCHEDULE FOR VEITHsymposium™
Wednesday, November 19, 2025
PresenterSESSION 31: ADVANCES IN MEDICAL DIAGNOSIS AND TREATMENTS IN VASCULAR PATIENTS; NEW ANTI-ATHEROGENIC DRUGS AND LIPID MANAGEMENT
The Importance Of LDL-C Lowering During A Lifetime And In Decreasing Dementia Risk: How Low To Strive For With Intensive Drug Therapy: How Young To Start If High; How Old To Continue Statins: Why And How Often Should LDL-C Levels Be Measured
7:22 AM - 7:27 AM
View Slides in PDF
Friday, November 21, 2025
PresenterSESSION 90: MORE HOT CAROTID TOPICS: TREATMENT IN 2025 OF EXTRACRANIAL CAROTID INFECTIONS AND ANEURYSMS, RECURRENT STENOSIS, WEBS, ETC.Update On Carotid Webs: Diagnosis, Symptoms/Morbidity And Optimal Current Treatment: Medical, Endo Or Open
2:48 PM - 2:53 PM
View Slides in PDF


Allan L. Brook, MDProfessor of Radiology and Neurosurgery
Albert Einstein College of Medicine
Director, Interventional Neuroradiology
Montefiore Medical Center
Bronx, New York

Benjamin S. Brooke, MD, PhDProfessor of Surgery
University of Utah School of Medicine
Chief, Division of Vascular Surgery
University of Utah Health
Park City, Utah
BENJAMIN S. BROOKE, MD, PHD - SCHEDULE FOR VEITHsymposium™
Wednesday, November 19, 2025
PresenterSESSION 36: MORE ISSUES IMPORTANT IN VASCULAR SURGERY: HISTORY, PRACTICE PATTERNS, VALUE OF GUIDELINES AND RCTS, MALPRACTICE, SCIENCE, TRAINING AND HUMAN BEHAVIORIn What Circumstances Can Nonoperative Management Improve Patient-Reported Outcomes As Revascularization: Does This Apply To Intermittent Claudication, Asymptomatic Carotid Stenosis, Small AAAs, Etc.
2:48 PM - 2:53 PM
View Slides in PDF
PresenterSESSION 36: MORE ISSUES IMPORTANT IN VASCULAR SURGERY: HISTORY, PRACTICE PATTERNS, VALUE OF GUIDELINES AND RCTS, MALPRACTICE, SCIENCE, TRAINING AND HUMAN BEHAVIORArtificial Intelligence Will Transform How Vascular Surgery Is Practiced: How Does It Work And How Will It Help: How Do Machine Learning, Algorithmic Learning And Enhanced Reality Fit In
3:06 PM - 3:11 PM
View Slides in PDF

Thomas G. Brott, MDProfessor of Neurology
Mayo Clinic College of Medicine
Neurologist
Mayo Clinic
Jacksonville, Florida
Kellie R. Brown, MDProfessor
The Medical College of Wisconsin
Senior Medical Director
Froedtert Memorial Lutheran Hospital
Milwaukee, Wisconsin
O. William Brown, MD, JDProfessor of Surgery
Oakland University William Beaumont School of Medicine and Wayne State Univ
Adjunct Professor of Law
Michigan State University College of Law
Chief, Section of Vascular Surgery
William Beaumont Hospital
Royal Oak, Michigan

Robert S. Brown, Jr., MD, MPHVincent Astor Distinguished Professor of Medicine
Weill Cornell Medical College
Chief Division of Gastroenterology and Hepatology
Weill Cornell Medicine
New York, New York
Elchanan Bruckheimer, MBBSDirector, Pediatric Cardiac Catheterization
Schneider Children's Medical Center Israel
Petah-Tikva, Israel

Richard Bulbulia, MA, MD, FRCSProfessor
CTSU, Nuffield Department of Population Health, University of Oxford
Consultant Vascular Surgeon
Gloucestershire Royal Hospital, UK
Oxford, United Kingdom
RICHARD BULBULIA, MA, MD, FRCS - SCHEDULE FOR VEITHsymposium™
Wednesday, November 19, 2025
PresenterSESSION 31: ADVANCES IN MEDICAL DIAGNOSIS AND TREATMENTS IN VASCULAR PATIENTS; NEW ANTI-ATHEROGENIC DRUGS AND LIPID MANAGEMENT
The Risk Of Arteriosclerosis And Its Complications Are Increased By LDL Cholesterol (LDL-C) Levels: What Are The Best Medical Strategies To Decrease These Complications: Statins, Adjunctive LDL-C Lowering Drugs - Inclisiran, Bempedoic Acid, Ezetimibe, PCSK-9 Inhibitors, Lepodisiran, Colchicine, Olezarsen: How They Should Be Administered
7:10 AM - 7:15 AM
View Slides in PDF
Friday, November 21, 2025
PresenterSESSION 89: MORE HOT CAROTID TOPICS: UPDATES ON KEY CAROTID RCTS AND TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS) AND POST-RADIATION STENOSISACST-2 Final Results: This RCT Found That CEA And CAS For ACS Had Comparable Stroke/Death Rates For 10 Years And Implied That Both Invasive Treatments Were Superior To Now Obsolete BMT: Why This Conclusion Is No Longer Applicable
1:24 PM - 1:29 PM
View Slides in PDF
PresenterSESSION 99: MEDICAL AND ADJUNCTIVE (DRUG AND CELL) TREATMENTS IN VASCULAR PATIENTS; A NEW CONCEPT; VASCULAR DISEASES; VASCULAR PROCEDURES TO FACILITATE OTHER SURGERIESLowering LDL-C And Controlling Elevated Blood Pressure And Lipoprotein Little A [Lp(a)] Can Lower Cardiovascular Risk 80%: What To Do If Patients Can't Tolerate A Statin Dose: Ezetimibe (Zetia), A PCSK9 Inhibitor, Inclisiran, Bempedoic Acid (Nexletol), Etc.
2:48 PM - 2:53 PM
View Slides in PDF
PresenterSESSION 99: MEDICAL AND ADJUNCTIVE (DRUG AND CELL) TREATMENTS IN VASCULAR PATIENTS; A NEW CONCEPT; VASCULAR DISEASES; VASCULAR PROCEDURES TO FACILITATE OTHER SURGERIESWhy A New Oral PCSK9 Inhibitor (AZD0780) Will Be A Game Changer In Lipid Management And Lowering The Morbidity Of Atherosclerosis: Implications Of Its Different Mode Of Action
3:06 PM - 3:11 PM
View Slides in PDF

Jacques Busquet, MDCardio-Vascular and Endovascular Surgeon
The Vivalto Foundation Group
Coordinator, Department of Vascular Surgery
Clinique Val D'Or - Saint Cloud
Paris, France
JACQUES BUSQUET, MD - SCHEDULE FOR VEITHsymposium™
Friday, November 21, 2025
Session ModeratorSESSION 88: MORE CAROTID RELATED NEW TOPICS RELATED TO GUIDELINES, TCAR, CAS, CEA, NEW DEVICES, MESH COVERED STENTS, DEALING WITH DISTAL (HIGH) CAROTID LESIONS, MINI-INCISION CEA AND TREATMENT OF POST-PROCEDURAL STROKESPresenterSESSION 90: MORE HOT CAROTID TOPICS: TREATMENT IN 2025 OF EXTRACRANIAL CAROTID INFECTIONS AND ANEURYSMS, RECURRENT STENOSIS, WEBS, ETC.In-Stent Stenosis After CAS: How Can It Be Predicted: When Is It Threatening And How Is It Best Managed
2:42 PM - 2:47 PM
View Slides in PDF
JACQUES BUSQUET, MD - ASSOCIATE FACULTY SCHEDULE FOR VEITHsymposium™
Wednesday, November 19, 2025
ModeratorSESSION 2: Abdominal Aorta – Part II MISCELLANEOUS ASSIGNMENTS AT VEITHsymposium
THE J. LEONEL VILLAVICENCIO LATIN AMERICAN PROGRAM AT VEITHsymposium
THURSDAY, NOVEMBER 20, 2025
MURRAY HILL SUITE EAST, 2ND FLOOR
MODERATOR
4:30 PM – 6:00 PM